Christopher Bayers

Christopher Bayers currently serves as the Director of Corporate Development at Quantum-Si, a position held since July 2024. Prior to this role, Christopher was the Director of Biopharma Business Development at Biofidelity from May 2022 to July 2024. Christopher's experience includes a tenure at Foundation Medicine from July 2018 to June 2022, where responsibilities encompassed various managerial and leadership roles in business development and clinical program support. Christopher holds two Master of Science degrees from Boston University School of Medicine in Medical Clinical Sciences and Clinical Investigation, along with a Bachelor of Science in Biological Sciences from Fordham University.